Nebraska Administrative Code
Topic - HEALTH AND HUMAN SERVICES SYSTEM
Title 180 - CONTROL OF RADIATION
Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL
Section 180-7-002 - DEFINITIONS

002.01 ACCREDITED INSTITUTION. A teaching facility for nuclear medicine technology or radiation therapy technology whose standards are accepted by the United States Department of Education.

002.02 ADDRESS OF USE. The address of the building or buildings identified on the license and where radioactive material may be produced, prepared, received, used, or stored.

002.03 AREA OF USE. The portion of an address of use set aside for the purpose of receiving, using, or storing radioactive material.

002.04 ASSOCIATE RADIATION SAFETY OFFICER (ARSO). An individual who:

002.05 AUTHORIZED MEDICAL PHYSICIST. An individual who:

002.06 AUTHORIZED NUCLEAR PHARMACIST. A pharmacist who:

002.07 AUTHORIZED USER. A physician, dentist, or podiatrist who:

002.08 BRACHYTHERAPY. A method of radiation therapy where plated, embedded, activated, or sealed sources are utilized to deliver a radiation dose at a distance of up to a few centimeters, by surface, intracavitary, intraluminal, or interstitial application.

002.09 BRACHYTHERAPY SOURCE. A radioactive source or a manufacturer-assembled source train or a combination of these sources designed to deliver a therapeutic dose within a distance of a few centimeters.

002.10 CLIENT'S ADDRESS. The address of use or a temporary job site for the purpose of providing mobile medical service according to 180 NAC 7-038.

002.11 DEDICATED CHECK SOURCE. A radioactive source used to assure the consistent response of a radiation detection or measurement device over several months or years.

002.12 DIAGNOSTIC CLINICAL PROCEDURES MANUAL. A collection of written procedures that describes each method, and other instructions and precautions, by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration, or in the case of sealed sources for diagnosis, the procedure.

002.13 HIGH DOSE-RATE (HDR) REMOTE AFTER LOADER. A device that remotely delivers a dose rate in excess of 12 gray (1200 rads) per hour at the treatment site.

002.14 LOW DOSE-RATE (LDR) REMOTE AFTERLOADER. A device that remotely delivers a dose rate of less than or equal to 2 gray (200 rads) per hour at the treatment site.

002.15 MANAGEMENT. The individual having the authority to manage, direct, or administer the licensee's activities, or that persons' designee or designees.

002.16 MANUAL BRACHYTHERAPY. A type of therapy where the brachytherapy sources are manually applied or inserted.

002.17 MEDICAL INSTITUTION. An organization where several medical disciplines are practiced.

002.18 MEDICAL USE. The intentional internal or external administration of radioactive material, or radiation from radioactive material to patients or human research subjects under the supervision of an authorized user.

002.19 MEDIUM DOSE-RATE (MDR) REMOTE AFTERLOADER . A brachytherapy device that remotely delivers a dose rate of greater than 2 gray (200 rads) per hour, but less than 12 gray (1200 rads) per hour at the point or surface where the dose is prescribed.

002.20 MISADMINISTRATION. An event that meets the criteria in 180 NAC 7-115.

002.21 MOBILE MEDICINE SERVICE. The transportation of radioactive material or its medical use at the client's address.

002.22 NUCLEAR MEDICINE TECHNOLOGIST. An individual who meets the requirements of 180 NAC 7-025.01 and is under the supervision of an authorized user, to prepare or administer radioactive drugs to patients or human research subjects, or perform in vivo or in vitro measurements for medical purposes.

002.23 NUCLEAR MEDICINE TECHNOLOGY. The science and art of in vivo or in vitro detection and measurement of radioactivity and the administration of radioactive drugs to patients or human research subjects for diagnostic and therapeutic purposes.

002.24 OPHTHALMIC PHYSICIST. An individual who:

002.25 OUTPUT. The exposure rate, dose rate, or a quantity related in a known manner to these rates from a brachytherapy source or a teletherapy, remote afterloader, or gamma stereotactic radiosurgery unit for a specified set of exposure conditions.

002.26 PATIENT INTERVENTION. Actions by the patient or human research subject, whether intentional or unintentional, dislodging or removing treatment devices or prematurely terminating the administration.

002.27 PRECEPTOR. An individual who provides, directs, or verifies training and experience required for an individual to become an authorized user, authorized medical physicist, authorized nuclear pharmacist, nuclear medicine technologist, radiation therapy technologist, RSO, or ARSO.

002.28 PRESCRIBED DOSAGE. A specified activity or range of activity of radioactive drug as documented:

002.29 PRESCRIBED DOSE. A prescribed dose means for:

002.30 PULSED DOSE-RATE (PDR) REMOTE AFTERLOADER . A special type of remote afterloading device that uses a single source capable of delivering dose rates in the "high dose-rate" range, but is:

002.31 RADIATION SAFETY OFFICER (RSO). An individual who:

002.32 RADIATION THERAPIST. An individual who meets the requirements of 180 NAC 7-025.02 and is under the supervision of an authorized user to perform procedures and apply radiation emitted from sealed radioactive sources to human beings for therapeutic purposes.

002.33 RADIATION THERAPY TECHNOLOGY. The science and art of applying radiation emitted from sealed radioactive sources to patients or human research subjects for therapeutic purposes.

002.34 RADIOACTIVE DRUG. Any chemical compound containing radioactive material that may be used on or administered to patients or human research subjects as an aid in the diagnosis, treatment, or prevention of disease or other abnormal condition.

002.35 SEALED SOURCE AND DEVICE REGISTRY. A national registry that contains all the registration certificates maintained by the NRC that summarize the radiation safety information for the sealed sources and devices and describe the licensing and use conditions approved for the product.

002.36 STEREOTACTIC RADIOSURGERY. The use of external radiation in conjunction with a stereotactic guidance device to precisely deliver a dose to a treatment site.

002.37 STRUCTURED EDUCATION PROGRAM. An educational program designed to impart particular knowledge and practical education through interrelated studies and supervised training.

002.38 TELETHERAPY. A method of radiation therapy where collimated gamma rays are delivered at a distance from the patient or human research subject.

002.39 TEMPORARY JOB SITE. A location where mobile medical services are conducted other than any location of use authorized on the license.

002.40 THERAPEUTIC DOSAGE. A radiation dosage of unsealed radioactive material intended to deliver a radiation dose to a patient or human research subject for palliative or curative treatment.

002.41 THERAPEUTIC DOSE. A radiation dose delivered from a source containing radioactive material to a patient or human research subject for palliative or curative treatment.

002.42 TREATMENT SITE. An anatomical description of the tissue intended to receive a radiation dose, as described in a written directive.

002.43 TYPE OF USE. The use of radioactive material as specified in 180 NAC 7-041, 7-044, 7-048, 7-055, 7-065, 7-067 or 7-085.

002.44 UNIT DOSAGE. A dosage that is:

002.45 WRITTEN DIRECTIVE. An authorized user's written order for the administration of a radioactive material or radiation from radioactive material to a specific patient or human research subject, as specified in 180 NAC 7-019.